UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 29, 2004
PACIFICHEALTH LABORATORIES, INC.
-----------------------------------------------------------
(Exact name of registrant as specified in charter)
Delaware 000-23495 22-3367588
------------------------------ ----------- ----------------------
(State or other (Commission (IRS Employer
jurisdiction of incorporation) File Number) Identification Number)
100 Matawan Road, Suite 420 Matawan, NJ 07747-3913
--------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (732) 739-2900
--------------
(Former name or former address, if changed since last report.)
Item 12. Results of Operations and Financial Condition.
On April 3, 2004, PacificHealth Laboratories, Inc. issued a press
release announcing certain financial results for the fiscal quarter ended March
31, 2004. The full text of the press release is attached hereto as Exhibit 99.1
to this Current Report on. Form 8-K.
On March 29, 2004, PacificHealth Laboratories, Inc. issued a press
release announcing certain financial results for the fiscal year ended December
31, 2004. The full text of the press release is attached hereto as Exhibit 99.2
to this Current Report on. Form 8-K.
The information in this Form 8-K and the attached exhibit shall not be deemed
"filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as
amended (the "Exchange Act") or otherwise subject to the liabilities of that
Section, or incorporated by reference in any filing under the Securities Act of
1933, as amended, or the Exchange Act, except as shall be expressly incorporated
by specific reference in such a filing.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
PACIFICHEALTH LABORATORIES, INC.
Dated: April 5, 2004 By: /s/ Stephen P. Kuchen
------------------------------------
Stephen P. Kuchen
Chief Financial Officer
Exhibit Index
Exhibit No. Description
----------- -----------
99.1 Press release dated April 2, 2004
99.2 Press release dated March 29, 2004